Innovation Pharmaceuticals Inc (IPIX)

[TheHound]

Innovation Pharmaceuticals Submits Material Transfer Agreement to Study Lead Defensin Mimetic Brilacidin for Coronavirus (COVID-19)

https://www.globenewswire.com/news-release/2020/02/24/1989322/0/en/Innovation-Pharmaceuticals-Submits-Material-Transfer-Agreement-to-Study-Lead-Defensin-Mimetic-Brilacidin-for-Coronavirus-COVID-19.html

---------------------------------------------------

Innovation Pharmaceuticals Exploring Lead Defensin Mimetic Drug Candidate Brilacidin as Potential Novel Coronavirus Treatment

https://www.globenewswire.com/news-release/2020/02/18/1986461/0/en/Innovation-Pharmaceuticals-Exploring-Lead-Defensin-Mimetic-Drug-Candidate-Brilacidin-as-Potential-Novel-Coronavirus-Treatment.html

---------------------------------------------------

http://www.ipharminc.com/new-blog/2020/2/18/shareholder-alert-defensins-are-conceptually-ideal-for-defense-against-different-viral-infections

https://www.washingtonpost.com/world/2020/01/22/mapping-spread-new-coronavirus/?arc404=true

https://www.theguardian.com/world/2020/feb/11/coronavirus-expert-warns-infection-could-reach-60-of-worlds-population

http://www.ipharminc.com/new-blog/2017/7/1/the-role-of-defensins-in-innate-immunity-and-the-host-defense-response

http://www.ipharminc.com/brilacidin-1

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933891/

https://www.washingtonpost.com/science/2020/02/14/inside-lab-where-scientists-are-working-urgently-fight-coronavirus-outbreak/

https://www.ecdc.europa.eu/en/factsheet-health-professionals-coronaviruses